Expanding a Biotech Into Europe: Determining Which Model to Use When Launching Your 1st Product & Building Country Operations

Expanding a Biotech Into Europe: Determining Which Model to Use When Launching Your 1st Product & Building Country Operations

This paper by Theo Manolikas (Principal, Blue Matter) and Michelle Lock (Sr. VP and Head of Europe and International, Acceleron Pharma) outlines 6 key models that biotech companies can use to guide the development of their European operations.

Logo